Please enable Javascript to get a taste of that Hopium 👼

BIIB - Company Overview - Biogen Inc
Biogen Inc
NASDAQ: biib

$197.11

USD

-$3.51

-1.75%

Prev Close

$200.62

Today's Open

$203.52

Volume

0.00

Market Cap

28.87B

Day Range

190.65

range triangle

199.26

52W Range

Price data unavailable

Overview

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.

Read more
Current Price
15 min delay
Catalysts

There are currently no catalysts for BIIB. If there's something you'd like to see, feel free to reach out to us on discord.

Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)

Insufficient Data

Ratios
Valuation Ratios

EPS (TTM)

9.77

P/E Ratio

20.17

Price to Sales

2.668

Price to Book

2.601

Profit Ratios

Profit Margin

13.40%

EBITDA Margin

33.47%

Net Profit Margin

82.00%

ROA

8.15%

Total Revenue

$10.82B

Net Profit

$8.87B

EV to EBITDA

12.11

EV to Revenue

3.057

Data source(s): Alpha Vantage